Related Experiment Video
Updated: Jun 13, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole
Rajendra J Kothavade1, M M Kura2, Arvind G Valand3
1Microbiology Section, WQA Laboratory, EPCOR, 9469 Rossdale Rd NW, Edmonton, AB T5K 0S5, Canada.
Abstract:
Candida tropicalis has been identified as the most prevalent pathogenic yeast species of the Candida-non-albicans group. Historically, Candida albicans has been the major species responsible for causing candidiasis in immunocompromised and immunocompetent patients. However, infections (candidiasis) due to C. tropicalis have increased dramatically on a global scale thus proclaiming this organism to be an emerging pathogenic yeast. The reasons for this organism's dominance and its resistance to fluconazole have been difficult to elucidate. In addition, the mechanism of this organism's pathogenicity and the consequent immune response remain to be clarified. This paper describes certain predisposing factors potentially responsible for these characteristics and presents a 'root cause analysis' to explain the increasing prevalence of C. tropicalis in developed and undeveloped countries, as well as the organism's acquired drug resistance. Control measures against fluconazole resistance in clinical management have also been discussed.
Insights
Candida tropicalis infections are rising globally, becoming a significant public health concern. This study analyzes factors driving its prevalence and fluconazole resistance, offering control strategies.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Candida tropicalis is an emerging pathogenic yeast, increasingly causing candidiasis globally.
- While Candida albicans was historically dominant, C. tropicalis now poses a significant threat, especially to vulnerable populations.
- The rise in C. tropicalis infections and its resistance to fluconazole require urgent investigation.
Purpose of the Study:
- To elucidate the reasons behind the increasing prevalence of Candida tropicalis.
- To understand the mechanisms of pathogenicity and immune response to C. tropicalis.
- To identify predisposing factors for C. tropicalis dominance and fluconazole resistance.
Main Methods:
- A root cause analysis approach was employed.
- Predisposing factors for C. tropicalis prevalence and drug resistance were investigated.
- Clinical management strategies for fluconazole resistance were discussed.
Main Results:
- The study identifies key factors contributing to the global rise of C. tropicalis.
- Mechanisms underlying C. tropicalis pathogenicity and immune evasion are explored.
- Acquired drug resistance, particularly to fluconazole, is a major concern.
Conclusions:
- Understanding the drivers of C. tropicalis emergence is crucial for public health.
- Addressing fluconazole resistance requires targeted control measures in clinical settings.
- Further research into C. tropicalis pathogenicity and host response is warranted.
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Antifungal Agents
Fungal Phylum Microsporidia
Trichomoniasis
Giardiasis

